Sana Biotechnology Inc (NASDAQ: SANA): Analyst View Points To Future Growth

Sana Biotechnology Inc (SANA) concluded trading on Wednesday at a closing price of $1.81, with 4.56 million shares of worth about $8.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -55.75% during that period and on March 26, 2025 the price saw a […]

Uncovering Institutional Buying In Sana Biotechnology Inc (NASDAQ: SANA)

Currently, there are 223.11M common shares owned by the public and among those 124.19M shares have been available to trade. The company’s stock has a 5-day price change of -17.09% and 11.76% over the past three months. SANA shares are trading 39.88% year to date (YTD), with the 12-month market performance down to -74.81% lower. […]

Sana Biotechnology Inc (NASDAQ: SANA) Not A Good Play Anymore?

Sana Biotechnology Inc (SANA) concluded trading on Wednesday at a closing price of $7.22, with 3.87 million shares of worth about $27.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.20% during that period and on Wednesday the price saw a gain of […]

An Important Check-Up On Sana Biotechnology Inc (NASDAQ: SANA)

Sana Biotechnology Inc (SANA) concluded trading on Thursday at a closing price of $6.16, with 9.27 million shares of worth about $57.13 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.80% during that period and on Thursday the price saw a gain of […]

Investors Should Take Note Of Sana Biotechnology Inc (SANA)

The Vanguard Group, Inc. has recently announced that it has increased stake in Sana Biotechnology Inc (NASDAQ:SANA) by 1.06%. After grabbing 9.01 million shares, the institutional investor is now in possession of 94420.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.57% having worth around $36.57 million. Moreover, […]

Some Investing Thoughts On Sana Biotechnology Inc (NASDAQ: SANA)

The Vanguard Group, Inc. has recently announced that it has increased stake in Sana Biotechnology Inc (NASDAQ:SANA) by 1.06%. After grabbing 9.01 million shares, the institutional investor is now in possession of 94420.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.57% having worth around $36.57 million. Moreover, […]